Drugs (Pharmaceuticals) – Page 29

As Covid Infections Rise, Nursing Homes Are Still Waiting for Vaccines

Now that the U.S. government has stepped back from issuing vaccines, long-term care operators have yet to start administering shots to protect one of the most vulnerable populations.

By Jordan Rau and Tony Leys

Colds Consumer Healthcare Products Assn Drugs (Pharmaceuticals) Food and Drug Administration Kennedy, John Fitzgerald Law and Legislation Leslie Hendeles Methamphetamines phenylephrine Pseudoephedrine (Drug) Regulation and Deregulation of Industry Waxman, Henry A

Why It Took So Long for the FDA to Tackle a Cold Medicine

Pharmacists affiliated with the University of Florida have spent decades nudging the agency to pull a decongestant from over-the-counter medicines.

By Christina Jewett

Antitrust Laws and Competition Issues Content Type: Service Drugs (Pharmaceuticals) Federal Trade Commission Generic Brands and Products GlaxoSmithKline PLC Inventions and Patents Regulation and Deregulation of Industry

Common Patenting Tactic by Drug Companies May Be Illegal, F.T.C. Says

Experts say the exploitation of a loophole in the patent system has contributed to high prices for inhalers.

By Rebecca Robbins

Drug Enforcement Administration Drugs (Pharmaceuticals) Ecstasy (Drug) Food and Drug Administration MAPS Public Benefit Corporation Post-Traumatic Stress Disorder Psychiatry and Psychiatrists Research Therapy and Rehabilitation

MDMA Therapy for PTSD Inches Closer to U.S. Approval

Results of a new study may offer regulators enough evidence to allow the psychedelic, also known as Ecstasy, to be considered for use as a PTSD treatment.

By Rachel Nuwer

mosaec